ES2113886T3 - Agentes anticancerosos basados en 1,2-dihidro-3h-dibenzisoquinolein-1,3-dionas. - Google Patents

Agentes anticancerosos basados en 1,2-dihidro-3h-dibenzisoquinolein-1,3-dionas.

Info

Publication number
ES2113886T3
ES2113886T3 ES91911663T ES91911663T ES2113886T3 ES 2113886 T3 ES2113886 T3 ES 2113886T3 ES 91911663 T ES91911663 T ES 91911663T ES 91911663 T ES91911663 T ES 91911663T ES 2113886 T3 ES2113886 T3 ES 2113886T3
Authority
ES
Spain
Prior art keywords
lower alkyl
taken together
independently hydrogen
aryl
carbon atoms
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91911663T
Other languages
English (en)
Inventor
David S Alberts
Robert T Dorr
William A Remers
Salah M Sami
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Research Corp Technologies Inc
Original Assignee
Research Corp Technologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Research Corp Technologies Inc filed Critical Research Corp Technologies Inc
Application granted granted Critical
Publication of ES2113886T3 publication Critical patent/ES2113886T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/04—Ortho- or peri-condensed ring systems
    • C07D221/18—Ring systems of four or more rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

LA INVENCION SE REFIERE A UN COMPUESTO UTIL EN EL TRATAMIENTO DE TUMORES QUE TIENE LA FORMULA (I), EN DONDE R8, R6 Y R10 SON INDEPENDIENTEMENTE HIDROGENO, ALQUIL INFERIOR, ALCANOIL INFERIOR, FORMIL, HALOGENO, NITRO, NR2R3, OR1 O SR1, METOXIDO, HIDROXIDO, CIANO CO2H, SO2NR1R2, O CONR1R2; R1, R2 Y R3 SON INDEPENDIENTEMENTE HIDROGENO, ALQUIL INFERIOR, ALQUIL INFERIOR DE ARIL, ARIL, FORMIL O ALCANOIL INFERIOR; R9, R11, R10 Y R7 SON INDEPENDIENTEMENTE HIDROGENO, ALQUIL INFERIOR O R9 Y R11 TOMADAS JUNTO CON LOS ATOMOS DE CARBONO A LOS CUALES ESTAN UNIDAS FORMAN UN GRUPO FENIL O R9 O R10 TOMADAS JUNTO CON LOS ATOMOS DE CARBONO A LOS CUALES ESTAN UNIDAS FORMAN UN GRUPO FENIL, O R7 Y R10 TOMADAS JUNTO CON LOS ATOMOS DE CARBONO A LOS CUALES ESTAN UNIDAS FORMAN UN GRUPO FENIL; A ES (CR4R5)M3, CICLOALQUIL INFERIOR O ARIL O UN ENLACE QUIMICO; CADA R4 Y R5 SON INDEPENDIENTEMENTE HIDROGENO O ALQUIL INFERIOR; R12 Y R13 SON INDEPENDIENTEMENTE HIDROGENO O ALQUIL INFERIOR QUE ESTA INSUBSTITUIDO O SUBSTITUIDOCON HIDROXIDO, MERCAPTO, ALCOXIDO INFERIOR, ALQUILCARBONILOXIDO INFERIOR, CARBOXIDO, O CARBOALCOXIDO INFERIOR, O R12 Y R13 TOMADAS JUNTO CON EL NITROGENO AL CUAL ESTAN UNIDAS FORMAN UN ANILLO HETEROCICLICO DE ENTRE 3 Y 6 MIEMBROS; D ES UN ENLACE QUIMICO O TOMADA JUNTO CON NR12 FORMA UN ANILLO HETEROCICLICO DE 5 O 6 MIEMBROS; N1 Y N2 SON INDEPENDIENTEMENTE 0, 1 O 2; Y N3 ES 0, 1, 2, 3, 4 O 5.
ES91911663T 1990-06-26 1991-06-19 Agentes anticancerosos basados en 1,2-dihidro-3h-dibenzisoquinolein-1,3-dionas. Expired - Lifetime ES2113886T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US54359690A 1990-06-26 1990-06-26

Publications (1)

Publication Number Publication Date
ES2113886T3 true ES2113886T3 (es) 1998-05-16

Family

ID=24168698

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91911663T Expired - Lifetime ES2113886T3 (es) 1990-06-26 1991-06-19 Agentes anticancerosos basados en 1,2-dihidro-3h-dibenzisoquinolein-1,3-dionas.

Country Status (9)

Country Link
EP (1) EP0536208B1 (es)
JP (1) JP2992769B2 (es)
AT (1) ATE162526T1 (es)
AU (1) AU643539B2 (es)
CA (1) CA2085598C (es)
DE (1) DE69128788T2 (es)
ES (1) ES2113886T3 (es)
IE (1) IE912200A1 (es)
WO (1) WO1992000281A1 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5635506A (en) * 1990-06-26 1997-06-03 Research Corporation Technologies, Inc. 1, 2-dihydro-3H-dibenzisoquinoline-1,3-dione anticancer agents
CA2144049A1 (en) * 1992-09-11 1994-03-31 David S. Alberts 1,2-dihydro-3h-dibenzisoquinoline-1,3-dione anticancer agents
US5703089A (en) * 1994-04-28 1997-12-30 Knoll Aktiengesellschaft Dihydrodibenzisoquinolinediones
SG73418A1 (en) * 1994-04-28 2000-06-20 Knoll Ag Novel dihydrodibenzoquinolinediones
EP0831094B1 (en) * 1995-05-31 2004-12-08 Eisai Co., Ltd. Fused polycyclic heterocycle derivatives
US6291425B1 (en) 1999-09-01 2001-09-18 Guilford Pharmaceuticals Inc. Compounds, methods and pharmaceutical compositions for treating cellular damage, such as neural or cardiovascular tissue damage
WO2008033891A2 (en) * 2006-09-12 2008-03-20 Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services Azonafide derived tumor and cancer targeting compounds
DE102007038422A1 (de) 2007-08-14 2009-02-19 Heinz Prof. Dr. Langhals Aceanthren- und Anthracencarbonsäureimide

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1253252A (en) * 1914-04-15 1918-01-15 Basf Ag Bluish-green vat dyes and process of making them.
US3940398A (en) * 1975-01-23 1976-02-24 E. R. Squibb & Sons, Inc. 2-[[4-(Azine or diazine or triazine)-1-piperazinyl]alkyl]-1H-benz[de]isoquinoline-1,3(2H)-diones
ES459497A1 (es) * 1977-06-04 1978-04-16 Made Labor Sa Un metodo para la preparacion industrial de naftalimidas y sus derivados.
US4665071A (en) * 1984-02-21 1987-05-12 Warner-Lambert Company 3,6-disubstituted-1,8-naphthalimides and methods for their production and use

Also Published As

Publication number Publication date
DE69128788T2 (de) 1998-06-10
IE912200A1 (en) 1992-01-01
AU8050191A (en) 1992-01-23
CA2085598A1 (en) 1991-12-27
ATE162526T1 (de) 1998-02-15
EP0536208A1 (en) 1993-04-14
AU643539B2 (en) 1993-11-18
EP0536208A4 (en) 1993-05-05
WO1992000281A1 (en) 1992-01-09
CA2085598C (en) 2002-09-17
EP0536208B1 (en) 1998-01-21
DE69128788D1 (de) 1998-02-26
JPH05508639A (ja) 1993-12-02
JP2992769B2 (ja) 1999-12-20

Similar Documents

Publication Publication Date Title
ATE184000T1 (de) 2-oxindolderivate als tyrosinekinaseinhibitoren
TR200101893T2 (tr) Antiviral maddeler olarak 4-okso-1,4 dihidro -3- kuinolinkarboksamitler.
DE69532817D1 (de) Verwendung von pyrazole verbindungen zur behandlung von glomerulonephritis, krebs, atherosklerose oder restenose
NO168705C (no) 3-nitro-kinoliner.
FI943646A0 (fi) Bentsosyklohepteenejä, bentsoksepiinejä bentsotiepiinejä
DK0918776T3 (da) Totalsyntese af antitumor acylfulvener
ES2064103T3 (es) Derivados de bifenil-guanidina sustituidos en posicion orto y agentes antidiabeticos o hipoglicemicos que los contienen.
ES2113886T3 (es) Agentes anticancerosos basados en 1,2-dihidro-3h-dibenzisoquinolein-1,3-dionas.
DK164554C (da) 3-vinyl- og 3-ethynyl-beta-carbolinderivater og fremgangsmaade til fremstilling heraf
ES2104848T3 (es) Complejos de renio y tecnecio que contienen un resto localizador de hipoxia.
ES426135A1 (es) Procedimiento de preparacion de esteres de aril-piperazino-alcanoles.
JPS55133363A (en) Novel 22sulfonyllquinoxaline
BG104037A (en) 6-pyrrolidin-2-ylpyrindine derivatives, their preparation and application in therapy
IN151285B (es)
BG102429A (en) Derivatives of 5-naphthalen-1-yl-1,3-dioxan, their preparation and usage as therapeutical means
DK0658555T3 (da) Pyridazinonderivater, fremgangsmåder til fremstilling deraf samt anvendelse deraf
MY101938A (en) Benzothiazoline fungicides
ATE148462T1 (de) Isoxazole derivate als lichtschutzmittel
FI854343A (fi) Foerfarande foer framstaellning av 3-amino-2,3-dihydro-1-benzoxepinfoereningar.
TH16053A (es)
ECSP951529A (es) Compuestos farmaceuticos

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 536208

Country of ref document: ES